SEIE - ETF AI Analysis

Top Page

SEI Select International Equity ETF (SEIE)

Rating:62Neutral

Price Target:―

The SEI Select International Equity ETF (SEIE) has an overall rating that reflects a mix of strong and moderate-performing holdings. Leading contributors include Novartis AG, which benefits from robust profitability and growth in key products, and GlaxoSmithKline, supported by solid financial performance and attractive valuation metrics. However, weaker holdings like Murata Manufacturing Co, with concerns about declining revenue growth and high valuation, may have tempered the fund's overall rating. A notable risk factor is the ETF's concentration in financial and pharmaceutical sectors, which could expose it to sector-specific volatility.

Positive Factors

Strong Top Holdings

Several of the ETF's largest positions, such as Barclays and Standard Chartered, have delivered strong year-to-date performance, supporting overall returns.

Global Diversification

The ETF offers exposure to a wide range of countries, including Japan, the UK, and Germany, reducing reliance on any single market.

Healthy Sector Spread

The fund is diversified across multiple sectors, with significant exposure to Financials, Industrials, and Consumer Cyclical industries.

Negative Factors

Underperforming Holding

SAP SE, one of the top holdings, has shown weak year-to-date performance, which could drag on the fund's returns.

Moderate Expense Ratio

The ETF's expense ratio of 0.5% is higher than some low-cost alternatives, potentially reducing net returns for investors.

Limited U.S. Exposure

With only 3.87% of the portfolio allocated to U.S. companies, the fund may miss out on opportunities in the world's largest economy.

SEIE vs. SPDR S&P 500 ETF (SPY)

AUM796.45M

RegionDeveloped Markets

Expense Ratio0.50%

Beta0.71

IssuerSEI

Inception DateOct 10, 2024

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume72,504

30 Day Avg. Volume78,784

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

35.74

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering347

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SEIE Summary

The SEI Select International Equity ETF (SEIE) is an investment fund that focuses on international stocks across various industries and regions. It includes companies from countries like Japan, the UK, and Germany, and holds well-known names such as HSBC Holdings and Novartis AG. This ETF is designed for investors looking to diversify their portfolio beyond domestic markets and gain exposure to global growth opportunities. However, new investors should be aware that the fund’s performance can be influenced by fluctuations in international markets and currency exchange rates.

How much will it cost me?The SEI Select International Equity ETF (SEIE) has an expense ratio of 0.5%, meaning you’ll pay $5 per year for every $1,000 invested. This is higher than average because it is actively managed, which typically involves more research and decision-making compared to passively managed funds that track an index.

What would affect this ETF?The SEI Select International Equity ETF (SEIE) could benefit from positive trends in developed markets outside the U.S., such as economic growth or technological advancements, particularly in sectors like financials and healthcare, which have significant weight in the fund. However, challenges like rising interest rates, geopolitical tensions, or regulatory changes in key regions could negatively impact its performance, especially for top holdings like HSBC and Novartis. Diversification across sectors and countries helps mitigate some risks but does not eliminate exposure to global economic uncertainties.

SEIE Top 10 Holdings

The SEI Select International Equity ETF is leaning heavily on financial stocks like HSBC and Barclays, which have been steady performers, buoyed by strong earnings and attractive valuations. Standard Chartered is rising fast, adding momentum to the fund's financial sector concentration. Meanwhile, healthcare names like Roche Holding and GlaxoSmithKline are providing a healthy dose of stability, though Novartis appears to be losing steam. With a focus on developed markets outside the U.S., the fund is well-diversified geographically but shows a clear tilt toward financials, which are driving much of its recent performance.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HSBA	HSBC Holdings	1.62%	$12.86M	£182.40B	42.82%	79 Outperform
BARC	Barclays	1.39%	$11.08M	£60.30B	64.05%	76 Outperform
GSK	GlaxoSmithKline	1.30%	$10.29M	£72.87B	34.30%	82 Outperform
NOVN	Novartis AG	1.26%	$10.02M	CHF203.80B	19.23%	80 Outperform
STAN	Standard Chartered	1.19%	$9.43M	£37.11B	77.20%	75 Outperform
ROG	Roche Holding AG	1.15%	$9.15M	CHF248.72B	32.86%	73 Outperform
INGA	ING GROEP	1.13%	$8.97M	€66.47B	50.52%	61 Neutral
	―	0.98%	$7.80M	―	―	―
MT	ArcelorMittal	0.92%	$7.28M	€27.22B	51.60%	73 Outperform
NWG	NatWest Group	0.91%	$7.22M	£49.40B	49.21%	76 Outperform

SEIE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

30.83

Positive

100DMA

30.30

Positive

200DMA

28.63

Positive

Market Momentum

MACD

0.25

Negative

RSI

61.15

Neutral

STOCH

63.02

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SEIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.26, equal to the 50-day MA of 30.83, and equal to the 200-day MA of 28.63, indicating a bullish trend. The MACD of 0.25 indicates Negative momentum. The RSI at 61.15 is Neutral, neither overbought nor oversold. The STOCH value of 63.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SEIE.

SEIE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SEIE	―	―	$796.45M	0.50%	―
DFSI	―	―	$893.12M	0.24%	―
FYLD	―	―	$481.01M	0.59%	―
AVSD	―	―	$394.22M	0.23%	―
TXUE	―	―	$293.04M	0.65%	―
PPIE	―	―	$274.00M	0.49%	―

Performance Comparison

SEIE

SEI Select International Equity ETF

31.68

7.42

30.59%

DFSI

Dimensional International Sustainability Core 1 ETF

―

FYLD

Cambria Foreign Shareholder Yield ETF

―

AVSD

Avantis Responsible International Equity ETF

―

TXUE

Thornburg International Equity ETF

―

PPIE

Putnam PanAgora ESG International Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents